価格表

在庫・価格 : 2024年05月02日 00時32分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-ATRX, Rabbit-Poly
データシート
NBP1-83077 NOVノバス バイオロジカルス
Novus biologicals, LLC
100 μl ¥127,000
(未発注)
追加

在庫・価格 : 2024年05月02日 00時32分 現在

Anti-ATRX, Rabbit-Poly

  • 商品コード:NBP1-83077
  • メーカー:NOV
  • 包装:100μl
  • 価格: ¥127,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 de Wilde RF et al. Loss of ATRX or DAXX expression and concomitant acquisition of the alternative lengthening of telomeres phenotype are late events in a small subset of MEN-1 syndrome pancreatic neuroendocrine tumors. Mod. Pathol. 2012 Jul;25(7):1033-9
de Wilde RF et al
2012/01/01
PubMed
2 Lovejoy CA et al. Loss of ATRX, Genome Instability, and an Altered DNA Damage Response Are Hallmarks of the Alternative Lengthening of Telomeres Pathway. PLoS Genet 2012 Jul;8(7):e1002772
Lovejoy CA et al
2012/01/01
PubMed
3 Bolander A et al. The protein expression of TRP-1 and galectin-1 in cutaneous malignant melanomas. Cancer Genomics Proteomics ;5(6):293-300
Bolander A et al
PubMed
4 Schwartzentruber J et al. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 2012 Feb;482(7384):226-31
Schwartzentruber J et al
2012/01/01
PubMed
5 Heaphy CM et al. Altered telomeres in tumors with ATRX and DAXX mutations. Science 2011 Jul;333(6041):425
Heaphy CM et al
2011/01/01
PubMed
6 Abedalthagafi M et al. The alternative lengthening of telomere phenotype is significantly associated with loss of ATRX expression in high-grade pediatric and adult astrocytomas: a multi-institutional study of 214 astrocytomas. Mod. Pathol. 2013 Nov;26(11)
Abedalthagafi M et al
2013/01/01
PubMed
7 Hayashi S et al. Molecular-genetic and clinical characteristics of gliomas with astrocytic appearance and total 1p19q loss in a single institutional consecutive cohort. Oncotarget 2015 Jun;6(18):15871-81
Hayashi S et al
2015/01/01
PubMed
8 Yoshida M et al. TERT promoter mutations are frequent and show association with MED12 mutations in phyllodes tumors of the breast. Br. J. Cancer 2015 Oct;113(8):1244-8
Yoshida M et al
2015/01/01
PubMed
9 Cryan JB et al. Clinical multiplexed exome sequencing distinguishes adult oligodendroglial neoplasms from astrocytic and mixed lineage gliomas. Oncotarget 2014 Sep;5(18):8083-92
Cryan JB et al
2014/01/01
PubMed
10 Cairncross JG et al. Benefit from procarbazine, lomustine, and vincristine in oligodendroglial tumors is associated with mutation of IDH. J. Clin. Oncol. 2014 Mar;32(8):783-90
Cairncross JG et al
2014/01/01
PubMed
11 Barszczyk M et al. Telomerase inhibition abolishes the tumorigenicity of pediatric ependymoma tumor-initiating cells. Acta Neuropathol. 2014 Dec;128(6):863-77
Barszczyk M et al
2014/01/01
PubMed
12 Nguyen DN et al. Molecular and morphologic correlates of the alternative lengthening of telomeres phenotype in high-grade astrocytomas. Brain Pathol. 2013 May;23(3):237-43
Nguyen DN et al
2013/01/01
PubMed
13 Fishbein L et al. Whole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas. Nat Commun 2015;6:6140
Fishbein L et al
2015/01/01
PubMed
14 Jiao Y et al. Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas. Oncotarget 2012 Jul;3(7):709-22
Jiao Y et al
2012/01/01
PubMed
15 Haberler C et al. Clinical Neuropathology practice news 2-2014: ATRX, a new candidate biomarker in gliomas. Clin. Neuropathol. ;33(2):108-11
Haberler C et al
PubMed
16 Napier CE et al. ATRX represses alternative lengthening of telomeres. Oncotarget 2015 Jun;6(18):16543-58
Napier CE et al
2015/01/01
PubMed
17 Gianno F et al. Correlation Between Immunohistochemistry and Sequencing in H3G34-Mutant Gliomas. Am J Surg Pathol 2021 02;45(2):200-204
Gianno F et al
2021/01/01
PubMed
18 Minasi S et al. Alternative lengthening of telomeres in molecular subgroups of paediatric high-grade glioma. Childs Nerv Syst 2021 03;37(3):809-818
Minasi S et al
2021/01/01
PubMed
  • No.: 1
  • 文献情報:
    de Wilde RF et al. Loss of ATRX or DAXX expression and concomitant acquisition of the alternative lengthening of telomeres phenotype are late events in a small subset of MEN-1 syndrome pancreatic neuroendocrine tumors. Mod. Pathol. 2012 Jul;25(7):1033-9
    de Wilde RF et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Lovejoy CA et al. Loss of ATRX, Genome Instability, and an Altered DNA Damage Response Are Hallmarks of the Alternative Lengthening of Telomeres Pathway. PLoS Genet 2012 Jul;8(7):e1002772
    Lovejoy CA et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Bolander A et al. The protein expression of TRP-1 and galectin-1 in cutaneous malignant melanomas. Cancer Genomics Proteomics ;5(6):293-300
    Bolander A et al
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Schwartzentruber J et al. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 2012 Feb;482(7384):226-31
    Schwartzentruber J et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Heaphy CM et al. Altered telomeres in tumors with ATRX and DAXX mutations. Science 2011 Jul;333(6041):425
    Heaphy CM et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Abedalthagafi M et al. The alternative lengthening of telomere phenotype is significantly associated with loss of ATRX expression in high-grade pediatric and adult astrocytomas: a multi-institutional study of 214 astrocytomas. Mod. Pathol. 2013 Nov;26(11)
    Abedalthagafi M et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Hayashi S et al. Molecular-genetic and clinical characteristics of gliomas with astrocytic appearance and total 1p19q loss in a single institutional consecutive cohort. Oncotarget 2015 Jun;6(18):15871-81
    Hayashi S et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Yoshida M et al. TERT promoter mutations are frequent and show association with MED12 mutations in phyllodes tumors of the breast. Br. J. Cancer 2015 Oct;113(8):1244-8
    Yoshida M et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Cryan JB et al. Clinical multiplexed exome sequencing distinguishes adult oligodendroglial neoplasms from astrocytic and mixed lineage gliomas. Oncotarget 2014 Sep;5(18):8083-92
    Cryan JB et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Cairncross JG et al. Benefit from procarbazine, lomustine, and vincristine in oligodendroglial tumors is associated with mutation of IDH. J. Clin. Oncol. 2014 Mar;32(8):783-90
    Cairncross JG et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Barszczyk M et al. Telomerase inhibition abolishes the tumorigenicity of pediatric ependymoma tumor-initiating cells. Acta Neuropathol. 2014 Dec;128(6):863-77
    Barszczyk M et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Nguyen DN et al. Molecular and morphologic correlates of the alternative lengthening of telomeres phenotype in high-grade astrocytomas. Brain Pathol. 2013 May;23(3):237-43
    Nguyen DN et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Fishbein L et al. Whole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas. Nat Commun 2015;6:6140
    Fishbein L et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Jiao Y et al. Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas. Oncotarget 2012 Jul;3(7):709-22
    Jiao Y et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Haberler C et al. Clinical Neuropathology practice news 2-2014: ATRX, a new candidate biomarker in gliomas. Clin. Neuropathol. ;33(2):108-11
    Haberler C et al
  • 備考:
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Napier CE et al. ATRX represses alternative lengthening of telomeres. Oncotarget 2015 Jun;6(18):16543-58
    Napier CE et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Gianno F et al. Correlation Between Immunohistochemistry and Sequencing in H3G34-Mutant Gliomas. Am J Surg Pathol 2021 02;45(2):200-204
    Gianno F et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Minasi S et al. Alternative lengthening of telomeres in molecular subgroups of paediatric high-grade glioma. Childs Nerv Syst 2021 03;37(3):809-818
    Minasi S et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed